Overview

Study Design of 'Influence of Sarpogrelate in Patients With Renal Impairment or Diabetes Mellitus' Study

Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The purpose of the SERENADE trial is to evaluate the safety and efficacy of sarpogrelate in patients with CKD or DM after DES implantation.
Phase:
Phase 3
Details
Lead Sponsor:
Seoul National University Bundang Hospital
Collaborator:
Yuhan Corporation
Treatments:
Aspirin
Clopidogrel
Sarpogrelate
Ticlopidine